A Novel Therapy

REIC PROTEIN INDUCED APOPTOSIS

MTG BIOTHERAPEUTICS IS DEVELOPING A PORTFOLIO OF IMMUNO-ONCOLOGY THERAPIES BASED ON REDUCED EXPRESSION OF THE DICKKOPF-3 GENE IN SOME CANCERS.

Prostate Cancer Therapy

TREATMENT OF AN UNMET MEDICAL NEED IN LOCALIZED PROSTATE CANCER WITHOUT RISK OF LONG TERM SIDE EFFECTS

Cutting Edge Research

A NOVEL IMMUNO-ONCOLOGY APPROACH TO TREATING MANY CANCERS

MTG-201 AND MTG-202 SELECTIVELY INDUCE APOPTOSIS IN CANCER CELLS THAT ARE REIC PROTEIN DEFICIENT DUE TO REDUCED EXPRESSION OF THE DICKKOPF-3 GENE. THIS DUAL MECHANICS OF ACTION BOTH DIRECTLY KILLS CANCER CELLS WHILE UPREGULATION THE IMMUNE SYSTEM AGAINST RESIDUAL DISEASE.

Therapy Concentration

Prostate Cancer

An unmet medical need in localized prostate cancer is for an effective treatment that preserves function. MTG Biotherapeutics seeks to provide men an option for treatment that is both safe and effective - and not have them wait until definitive therapy is needed or their cancer metastasizes.

More

Mesothelioma

Mesothelioma is one of the most lethal cancers with a high unmet medical need. Current therapies have limited effect. There is an urgent need for a more effective treatment that gives hope of survival.

 

 

More

Invasive Bladder Cancer

Invasive Bladder Cancer is a poorly treated cancer where the cancer cells have spread beyond the inner lining of the bladder and into muscle tissue. If not treated, invasive bladder cancer can lead to the removal of the bladder or metastatic disease.

 

More

Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC) is a primary malignancy of the liver. While an Orphan disease in the United States, due to wide spread Hepatitis, HCC is a the third leading cause of cancer death worldwide.

 

More